Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 2,130,858	$ 1,500,357
Short-term investments.		240,000
Accounts receivable, net	544,961	1,167,473
Inventories	141,956	118,205
Prepaid expenses and other assets	386,200	264,691
Total current assets	3,203,975	3,290,726
Property and equipment, net	13,532,399	13,528,806
Goodwill	98,134	98,134
Trade names	500,525	500,525
Other long-term assets	1,909,925	1,300,804
Total assets	19,244,958	18,718,995
Current liabilities:
Current portion of long-term debt	1,009,741	876,890
Accounts payable	91,786	233,172
Accrued expenses and other liabilities	1,097,523	1,058,401
Due to NCLH	40,459	37,995
Advance ticket sales	1,977,325	1,561,336
Total current liabilities	4,216,834	3,767,794
Long-term debt	10,394,517	9,863,980
Exchangeable notes	2,352,435	1,801,517
Other long-term liabilities	1,007,692	997,055
Total liabilities	17,971,478	16,430,346
Commitments and contingencies (Note 9)
Shareholders' equity:
Preference shares (Series A-1: $1,000 par value; 2,000,000 shares authorized; 0 shares issued and outstanding at Mar 31, 2022 and Dec 31, 2021; Series A-3: $1,000 par value; 1,000,000 shares authorized; 0 shares issued and outstanding at Mar 31, 2022 and Dec 31, 2021; Series A-4: $1,000 par value; 2,000,000 shares authorized; 0 shares issued and outstanding at Mar 31, 2022 and Dec 31, 2021; and Series A-5: $1,000 par value; 1,000,000 shares authorized; 0 shares issued and outstanding at Mar 31, 2022)
Ordinary shares ($0.0012 par value; 40,000,000 shares authorized; 31,164,004 shares issued and outstanding at March 31, 2022 and December 31, 2021)	37	37
Additional paid-in capital	8,510,601	8,489,770
Accumulated other comprehensive income (loss)	(252,521)	(286,799)
Accumulated deficit	(6,984,637)	(5,914,359)
Total shareholders' equity	1,273,480	2,288,649
Total liabilities and shareholders' equity	$ 19,244,958	$ 18,718,995